AURA Aura Biosciences Inc: Sof foyda bo'yicha sotuv rentabelligi

Aura Biosciences, Inc. (AURA) grafik logotipi

Aura Biosciences, Inc. (AURA) xarajatlarni kamaytirish maqsadida dastlabki sinovlarni akademik hamkorlarga topshirish orqali belzupacap sarotalocan dorisining klinik sinovlarini kengaytirmoqda. GURU.Markets grafigidagi kunlik narx harakatlaridagi sof foyda marjasi hozirda biznes samaradorligini baholashga yordam beradigan 0.00 parametriga ega. Kompaniya atrofidagi to'qimalarning holatini saqlagan holda, saraton hujayralarini aniq yo'q qiluvchi noyob viral konjugatlarni ishlab chiqadi.

Aura Corp (AURA) - Sof marja 04.07.2022dan 20.11.2026gacha

Aura Biosciences, Inc. kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- pul mablag'lari va pul harakati tafsilotlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Aura Biosciences Inc - AURA
Aura Bio ishlab chiqargan mahsulot

Ushbu ko'rsatkich sof foydaning tushumga nisbatini aks ettiradi va barcha xarajatlar chegirib tashlanganidan keyin daromadning har bir dollari qanchalik samaradorlik bilan yakuniy moliyaviy natijaga aylantirilganini baholash imkonini beradi. Onkologik biotexnologiya ishlanmalari kontekstida, savdo marjalari Aura Biosciences, Inc. (AURA) ning klinik sinovlari davomida xomashyo ta'minoti zanjirlarining qat'iy boshqaruvi va shartnomalarning diversifikatsiyasi operatsion yo'qotishlarni qanday minimallashtirishini ko'rsatadi.

Asosiy raqobatchilar

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|Candel Therapeutics Inc. - Sof foyda normasi|Sof marja Accuray Inc.|Sof marja SELLAS Life Sciences Group SLS|Sotuvning sof marjinal rentabelligi ACTU|CTOR - Sof marja|Sotuvning sof marjinal rentabelligi HURA (TuHURA Biosciences, Inc.)|Sof foyda normasi TARA|FATE: Sof foyda bo'yicha sotuv rentabelligi|WHWK (aadibio.com) - Sotuvning sof rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)